0512.HK HKSE
Grand Pharmaceutical Group Limited
1W: -0.6%
1M: -1.2%
3M: -10.9%
YTD: -39.2%
1Y: -41.8%
3Y: +20.3%
5Y: -16.4%
HK$4.73 ($0.60)
-0.07 (-1.46%)
Weekly Expected Move ±3.9%
HK$4
HK$5
HK$5
HK$5
HK$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#3
of 9
Medical - Pharmaceuticals
Technical Signal Map
2 Bullish
2 Neutral
5 Bearish
0512.HK
$17B
Grand Pharmaceutical Group Limited
LEAN BEAR
-24
2005.HK
$8.2B
SSY Group Limited
BULLISH
+42
1889.HK
$30M
Sanai Health Industry Group Company Limited
LEAN BULL
+14
0575.HK
$250M
Regent Pacific Group Limited
NEUTRAL
+8
1177.HK
$102B
Sino Biopharmaceutical Limited
NEUTRAL
-8
3320.HK
$28B
China Resources Pharmaceutical Group Ltd.
LEAN BEAR
-24
0950.HK
$710M
Lee's Pharmaceutical Holdings Limited
BEARISH
-33
3390.HK
$220M
Tycoon Group Holdings Limited
BEARISH
-35
3613.HK
$4.7B
Beijing Tong Ren Tang Chinese Medicine Company Limited
BEARISH
-41
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 0512.HK Grand Pharmaceutical Group Limited | $17B | 14.8 | 19.5 | 11.7 | 16.6 | 16.0 | 6 | LEAN BEAR | -41.8 |
| 2005.HK SSY Group Limited | $8.2B | 15.8 | 15.5 | 12.9 | 13.6 | -30.2 | 4 | BULLISH | -7.6 |
| 1889.HK Sanai Health Industry Group Company Limited | $30M | — | — | — | — | — | — | LEAN BULL | — |
| 0575.HK Regent Pacific Group Limited | $250M | -16.1 | 119.1 | -279.8 | 10.3 | 1355.9 | 5 | NEUTRAL | -6.1 |
| 1177.HK Sino Biopharmaceutical Limited | $102B | 35.6 | 21.1 | 40.0 | 17.7 | 28.2 | 7 | NEUTRAL | -28.2 |
| 3320.HK China Resources Pharmaceutical Group Ltd. | $28B | 5.7 | 13.7 | 15.6 | 1.6 | 8.8 | 6 | LEAN BEAR | -17.5 |
| 0950.HK Lee's Pharmaceutical Holdings Limited | $710M | 4.1 | 9.3 | 0.6 | 11.9 | 34.9 | 8 | BEARISH | -45.1 |
| 3390.HK Tycoon Group Holdings Limited | $220M | 6.9 | 0.9 | 5.1 | 1.4 | -8.9 | 1 | BEARISH | -20.9 |
| 3613.HK Beijing Tong Ren Tang Chinese Medicine Company Limited | $4.7B | 9.9 | 12.3 | 24.2 | 32.9 | -0.0 | 8 | BEARISH | -40.1 |
| 0512.HK Grand Pharmaceutical Group Limited | $17B | 14.8 | 19.5 | 11.7 | 16.6 | 16.0 | 6 | LEAN BEAR | -41.8 |
| 2005.HK SSY Group Limited | $8.2B | 15.8 | 15.5 | 12.9 | 13.6 | -30.2 | 4 | BULLISH | -7.6 |
| 1889.HK Sanai Health Industry Group Company Limited | $30M | — | — | — | — | — | — | LEAN BULL | — |
| 0575.HK Regent Pacific Group Limited | $250M | -16.1 | 119.1 | -279.8 | 10.3 | 1355.9 | 5 | NEUTRAL | -6.1 |
| 1177.HK Sino Biopharmaceutical Limited | $102B | 35.6 | 21.1 | 40.0 | 17.7 | 28.2 | 7 | NEUTRAL | -28.2 |
| 3320.HK China Resources Pharmaceutical Group Ltd. | $28B | 5.7 | 13.7 | 15.6 | 1.6 | 8.8 | 6 | LEAN BEAR | -17.5 |
| 0950.HK Lee's Pharmaceutical Holdings Limited | $710M | 4.1 | 9.3 | 0.6 | 11.9 | 34.9 | 8 | BEARISH | -45.1 |
| 3390.HK Tycoon Group Holdings Limited | $220M | 6.9 | 0.9 | 5.1 | 1.4 | -8.9 | 1 | BEARISH | -20.9 |
| 3613.HK Beijing Tong Ren Tang Chinese Medicine Company Limited | $4.7B | 9.9 | 12.3 | 24.2 | 32.9 | -0.0 | 8 | BEARISH | -40.1 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
0512.HK vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F